Aionios Pharma Private Limited - Company Profile

It is a business services private limited company based in Bangalore North, Karnataka, India, established in 2024.
2024 Bangalore North, Karnataka, India Active
Last Updated:
Access Report
About Aionios Pharma Private Limited

Aionios Pharma Private Limited, a active private limited company, was established on 26 February 2024 in Bangalore North, Karnataka, India. it holds CIN: U46497KA2024PTC185375. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹7.25 Cr and a paid-up capital of ₹7.21 Cr.

Its leadership includes Raja Namakkal Kandasamy (Managing Director), Namakkal Kandasamy Sathiyamoorthy (Director). It holds ₹1.75 Cr open charges and no settled loans. It is based at Unit No. 105, First Floor, Sufia Elite, No. 18/1, Cunningham Road, Bangalore North, Karnataka, 560001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U46497KA2024PTC185375

  • Registration Number

    185375

  • Incorporation Date

    26 February 2024

  • Authorized Capital

    ₹7.25 Cr

  • Paid-Up Capital

    ₹7.21 Cr

  • ROC Code

    Roc Bangalore

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 7.25 Cr
  • Paid Up Capital ₹ 7.21 Cr
  • Company Age 2 Year, 8 Days
  • Open Charges ₹ 1.75 Cr
Company report

Aionios Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Aionios Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Aionios Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Raja Namakkal Kandasamy Managing Director 26 Feb 2024 Current
Namakkal Kandasamy Sathiyamoorthy Director 26 Feb 2024 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Aionios Pharma.

Enhance accessibility to Aionios Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Aionios Pharma revenue growth over time
Aionios Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Aionios Pharma?

Unlock access to Aionios Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹17,500,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • City Union Bank Limited : 1.75 Cr
Latest Charge Details
Date Lender Amount Status
16 Aug 2025 City Union Bank Limited ₹1.75 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Aionios Pharma?

Aionios Pharma has a workforce of 0 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Aionios Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aionios Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Aionios Pharma
Recent Activity within the Organization
  • Charges

    A charge with City Union Bank Limited amounted to Rs. 1.75 Cr with Charge ID 101139201 was registered on 16 Aug 2025. was recorded as a recent event.

  • Director Appointment

    The activity Raja Namakkal Kandasamy was appointed as a Managing Director was appointed as a Managing Director on 26 Feb 2024 & has been associated with this company since 2 years 8 days . was completed.

  • Director Appointment

    The activity Namakkal Kandasamy Sathiyamoorthy was appointed as a Director was appointed as a Director on 26 Feb 2024 & has been associated with this company since 2 years 8 days . was completed.

  • Company Incorporation

    The activity Aionios Pharma Private Limited was registered on 26 Feb 2024 with Roc Bangalore & aged 2 years 8 days as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Aionios Pharma Private Limited?

The CIN of Aionios Pharma Private Limited is U46497KA2024PTC185375.

Where is Aionios Pharma Private Limited headquartered?

Aionios Pharma Private Limited is headquartered at Unit No. 105, First Floor, Sufia Elite, No. 18/1, Cunningham Road, Bangalore North, Karnataka, 560001.

When was Aionios Pharma Private Limited incorporated?

Aionios Pharma Private Limited was incorporated on 26 February 2024.

Who are the current directors of Aionios Pharma Private Limited?

The current directors of Aionios Pharma Private Limited are

Is Aionios Pharma Private Limited a listed company?

Aionios Pharma Private Limited is unlisted.

What is the capital structure of Aionios Pharma Private Limited?

The authorized capital of Aionios Pharma Private Limited is ₹7.25 Cr, and the paid-up capital is ₹7.21 Cr.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available